View Item 

Show simple item record

Bisphenol A‐associated alterations in the expression and epigenetic regulation of genes encoding xenobiotic metabolizing enzymes in human fetal liver
dc.contributor.authorNahar, Muna S.en_US
dc.contributor.authorKim, Jung H.en_US
dc.contributor.authorSartor, Maureen A.en_US
dc.contributor.authorDolinoy, Dana C.en_US
dc.date.accessioned2014-05-21T18:02:38Z
dc.date.availableWITHHELD_13_MONTHSen_US
dc.date.available2014-05-21T18:02:38Z
dc.date.issued2014-04en_US
dc.identifier.citationNahar, Muna S.; Kim, Jung H.; Sartor, Maureen A.; Dolinoy, Dana C. (2014). "Bisphenol A‐associated alterations in the expression and epigenetic regulation of genes encoding xenobiotic metabolizing enzymes in human fetal liver." Environmental and Molecular Mutagenesis 55(3): 184-195.en_US
dc.identifier.issn0893-6692en_US
dc.identifier.issn1098-2280en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/106679
dc.publisherWiley Periodicals, Inc.en_US
dc.subject.otherTranscription Factoren_US
dc.subject.otherXenobiotic Metabolismen_US
dc.subject.otherLiveren_US
dc.subject.otherDNA Methylationen_US
dc.subject.otherBisphenol Aen_US
dc.titleBisphenol A‐associated alterations in the expression and epigenetic regulation of genes encoding xenobiotic metabolizing enzymes in human fetal liveren_US
dc.typeArticleen_US
dc.rights.robotsIndexNoFollowen_US
dc.subject.hlbsecondlevelBiological Chemistryen_US
dc.subject.hlbsecondlevelGeneticsen_US
dc.subject.hlbsecondlevelMolecular, Cellular and Developmental Biologyen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.subject.hlbtoplevelScienceen_US
dc.description.peerreviewedPeer Revieweden_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/106679/1/em21823.pdf
dc.identifier.doi10.1002/em.21823en_US
dc.identifier.sourceEnvironmental and Molecular Mutagenesisen_US
dc.identifier.citedreferenceSengupta S, Bolin JM, Ruotti V, Nguyen BK, Thomson JA, Elwell AL, Stewart R. 2011. Single read and paired end mRNA‐Seq Illumina libraries from 10 nanograms total RNA. J Vis Exp: e3340.en_US
dc.identifier.citedreferenceKundakovic M, Champagne FA. 2011. Epigenetic perspective on the developmental effects of bisphenol A. Brain Behav Immun 25: 1084 – 1093.en_US
dc.identifier.citedreferenceKyriakis JM, Avruch J. 2001. Mammalian mitogen‐activated protein kinase signal transduction pathways activated by stress and inflammation. Physiol Rev 81: 807 – 869.en_US
dc.identifier.citedreferenceMcCarver DG, Hines RN. 2002. The ontogeny of human drug‐metabolizing enzymes: Phase II conjugation enzymes and regulatory mechanisms. J Pharmacol Exp Ther 300: 361 – 366.en_US
dc.identifier.citedreferenceMolina‐Molina JM, Amaya E, Grimaldi M, Saenz JM, Real M, Fernandez MF, Balaguer P, Olea N. 2013. In vitro study on the agonistic and antagonistic activities of bisphenol‐S and other bisphenol‐A congeners and derivatives via nuclear receptors. Toxicol Appl Pharmacol 272: 127 – 136.en_US
dc.identifier.citedreferenceNaciff JM, Khambatta ZS, Reichling TD, Carr GJ, Tiesman JP, Singleton DW, Khan SA, Daston GP. 2010. The genomic response of Ishikawa cells to bisphenol A exposure is dose‐ and time‐dependent. Toxicology 270: 137 – 149.en_US
dc.identifier.citedreferenceNahar MS, Liao C, Kannan K, Dolinoy DC. 2012. Fetal liver bisphenol A concentrations and biotransformation gene expression reveal variable exposure and altered capacity for metabolism in humans. J Biochem Mol Toxicol 27: 116 – 123.en_US
dc.identifier.citedreferenceO'Shaughnessy PJ, Monteiro A, Bhattacharya S, Fraser MJ, Fowler PA. 2013. Steroidogenic enzyme expression in the human fetal liver and potential role in the endocrinology of pregnancy. Mol Hum Reprod 19: 177 – 187.en_US
dc.identifier.citedreferenceOmiecinski CJ, Aicher L, Swenson L. 1994. Developmental expression of human microsomal epoxide hydrolase. J Pharmacol Exp Ther 269: 417 – 423.en_US
dc.identifier.citedreferencePfeiffer E, Metzler M. 2004. Effect of bisphenol A on drug metabolising enzymes in rat hepatic microsomes and precision‐cut rat liver slices. Arch Toxicol 78: 369 – 377.en_US
dc.identifier.citedreferenceRubin BS. 2011. Bisphenol A: an endocrine disruptor with widespread exposure and multiple effects. J Steroid Biochem Mol Biol 127: 27 – 34.en_US
dc.identifier.citedreferenceSaghir SA, Khan SA, McCoy AT. 2012. Ontogeny of mammalian metabolizing enzymes in humans and animals used in toxicological studies. Crit Rev Toxicol 42: 323 – 357.en_US
dc.identifier.citedreferenceSchonfelder G, Wittfoht W, Hopp H, Talsness CE, Paul M, Chahoud I. 2002. Parent bisphenol A accumulation in the human maternal‐fetal‐placental unit. Environ Health Perspect 110: 703 – 707.en_US
dc.identifier.citedreferenceSmith M, Hopkinson DA, Harris H. 1971. Developmental changes and polymorphism in human alcohol dehydrogenase. Ann Hum Genet 34: 251 – 271.en_US
dc.identifier.citedreferenceSmyth GK. 2004. Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol 3: Article3.en_US
dc.identifier.citedreferenceStrange RC, Howie AF, Hume R, Matharoo B, Bell J, Hiley C, Jones P, Beckett GJ. 1989. The development expression of alpha‐, mu‐ and pi‐class glutathione S ‐transferases in human liver. Biochim Biophys Acta 993: 186 – 190.en_US
dc.identifier.citedreferenceSuganuma T, Workman JL. 2012. MAP kinases and histone modification. J Mol Cell Biol 4: 348 – 350.en_US
dc.identifier.citedreferenceTimens W, Kamps WA. 1997. Hemopoiesis in human fetal and embryonic liver. Microsc Res Tech 39: 387 – 397.en_US
dc.identifier.citedreferenceVogel C, Marcotte EM. 2012. Insights into the regulation of protein abundance from proteomic and transcriptomic analyses. Nat Rev Genet 13: 227 – 232.en_US
dc.identifier.citedreferenceWang H, Ping J, Peng RX, Yue J, Xia XY, Li QX, Kong R, Hong JY. 2008. Changes of multiple biotransformation phase I and phase II enzyme activities in human fetal adrenals during fetal development. Acta Pharmacol Sin 29: 231 – 238.en_US
dc.identifier.citedreferenceWatanabe H, Adachi R, Kusui K, Hirayama A, Kasahara T, Suzuki K. 2003. Bisphenol A significantly enhances the neutrophilic differentiation of promyelocytic HL‐60 cells. Int Immunopharmacol 3: 1601 – 1608.en_US
dc.identifier.citedreferenceWatson CS, Jeng YJ, Guptarak J. 2011. Endocrine disruption via estrogen receptors that participate in nongenomic signaling pathways. J Steroid Biochem Mol Biol 127: 44 – 50.en_US
dc.identifier.citedreferenceWetherill YB, Akingbemi BT, Kanno J, McLachlan JA, Nadal A, Sonnenschein C, Watson CS, Zoeller RT, Belcher SM. 2007. In vitro molecular mechanisms of bisphenol A action. Reprod Toxicol 24: 178 – 198.en_US
dc.identifier.citedreferenceYordy JS, Muise‐Helmericks RC. 2000. Signal transduction and the Ets family of transcription factors. Oncogene 19: 6503 – 6513.en_US
dc.identifier.citedreferenceAlcorn J, McNamara PJ. 2003. Pharmacokinetics in the newborn. Adv Drug Deliv Rev 55: 667 – 686.en_US
dc.identifier.citedreferenceAllegaert K, van den Anker JN, Naulaers G, de Hoon J. 2007. Determinants of drug metabolism in early neonatal life. Curr Clin Pharmacol 2: 23 – 29.en_US
dc.identifier.citedreferenceAllegaert K, Verbesselt R, Naulaers G, van den Anker JN, Rayyan M, Debeer A, de Hoon J. 2008. Developmental pharmacology: neonates are not just small adults. Acta Clin Belg 63: 16 – 24.en_US
dc.identifier.citedreferenceAnderson OS, Nahar MS, Faulk C, Jones TR, Liao C, Kannan K, Weinhouse C, Rozek LS, Dolinoy DC. 2012. Epigenetic responses following maternal dietary exposure to physiologically relevant levels of bisphenol A. Environ Mol Mutagen 53: 334 – 342.en_US
dc.identifier.citedreferenceBalakrishnan B, Henare K, Thorstensen EB, Ponnampalam AP, Mitchell MD. 2010. Transfer of bisphenol A across the human placenta. Am J Obstet Gynecol 202: 393 e391 – e397.en_US
dc.identifier.citedreferenceBassuk AG, Leiden JM. 1995. A direct physical association between ETS and AP‐1 transcription factors in normal human T cells. Immunity 3: 223 – 237.en_US
dc.identifier.citedreferenceBenjamini Y, Hochberg Y. 1995. Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing. J R Stat Soc Series B Stat Methodol 57: 289 – 300.en_US
dc.identifier.citedreferenceBromer JG, Zhou Y, Taylor MB, Doherty L, Taylor HS. 2010. Bisphenol‐A exposure in utero leads to epigenetic alterations in the developmental programming of uterine estrogen response. FASEB J 24: 2273 – 2280.en_US
dc.identifier.citedreferenceButerin T, Koch C, Naegeli H. 2006. Convergent transcriptional profiles induced by endogenous estrogen and distinct xenoestrogens in breast cancer cells. Carcinogenesis 27: 1567 – 1578.en_US
dc.identifier.citedreferenceCaldwell J, Gardner I, Swales N. 1995. An introduction to drug disposition: the basic principles of absorption, distribution, metabolism, and excretion. Toxicol Pathol 23: 102 – 114.en_US
dc.identifier.citedreferenceCao XL, Zhang J, Goodyer CG, Hayward S, Cooke GM, Curran IH. 2012. Bisphenol A in human placental and fetal liver tissues collected from Greater Montreal area (Quebec) during 1998–2008. Chemosphere 89: 505 – 511.en_US
dc.identifier.citedreferenceCartharius K, Frech K, Grote K, Klocke B, Haltmeier M, Klingenhoff A, Frisch M, Bayerlein M, Werner T. 2005. MatInspector and beyond: promoter analysis based on transcription factor binding sites. Bioinformatics 21: 2933 – 2942.en_US
dc.identifier.citedreferenceChepelev NL, Enikanolaiye MI, Chepelev LL, Almohaisen A, Chen Q, Scoggan KA, Coughlan MC, Cao XL, Jin X, Willmore WG. 2013. Bisphenol A activates the Nrf1/2‐antioxidant response element pathway in HEK 293 cells. Chem Res Toxicol 26: 498 – 506.en_US
dc.identifier.citedreferenceCoolen MW, Statham AL, Gardiner‐Garden M, Clark SJ. 2007. Genomic profiling of CpG methylation and allelic specificity using quantitative high‐throughput mass spectrometry: critical evaluation and improvements. Nucleic Acids Res 35: e119.en_US
dc.identifier.citedreferenceDuanmu Z, Weckle A, Koukouritaki SB, Hines RN, Falany JL, Falany CN, Kocarek TA, Runge‐Morris M. 2006. Developmental expression of aryl, estrogen, and hydroxysteroid sulfotransferases in pre‐ and postnatal human liver. J Pharmacol Exp Ther 316: 1310 – 1317.en_US
dc.identifier.citedreferenceHanet N, Lancon A, Delmas D, Jannin B, Chagnon MC, Cherkaoui‐Malki M, Latruffe N, Artur Y, Heydel JM. 2008. Effects of endocrine disruptors on genes associated with 17beta‐estradiol metabolism and excretion. Steroids 73: 1242 – 1251.en_US
dc.identifier.citedreferenceHanioka N, Jinno H, Tanaka‐Kagawa T, Nishimura T, Ando M. 2000. Interaction of bisphenol A with rat hepatic cytochrome P450 enzymes. Chemosphere 41: 973 – 978.en_US
dc.identifier.citedreferenceHanioka N, Takeda Y, Tanaka‐Kagawa T, Hayashi K, Jinno H, Narimatsu S. 2008. Interaction of bisphenol A with human UDP‐glucuronosyltransferase 1A6 enzyme. Environ Toxicol 23: 407 – 412.en_US
dc.identifier.citedreferenceHines RN. 2007. Ontogeny of human hepatic cytochromes P450. J Biochem Mol Toxicol 21: 169 – 175.en_US
dc.identifier.citedreferenceHines RN. 2008. The ontogeny of drug metabolism enzymes and implications for adverse drug events. Pharmacol Ther 118: 250 – 267.en_US
dc.identifier.citedreferenceHines RN, McCarver DG. 2002. The ontogeny of human drug‐metabolizing enzymes: phase I oxidative enzymes. J Pharmacol Exp Ther 300: 355 – 360.en_US
dc.identifier.citedreferenceHo SM, Tang WY, Belmonte de Frausto J, Prins GS. 2006. Developmental exposure to estradiol and bisphenol A increases susceptibility to prostate carcinogenesis and epigenetically regulates phosphodiesterase type 4 variant 4. Cancer Res 66: 5624 – 5632.en_US
dc.identifier.citedreferenceHogart A, Lichtenberg J, Ajay SS, Anderson S, Margulies EH, Bodine DM. 2012. Genome‐wide DNA methylation profiles in hematopoietic stem and progenitor cells reveal overrepresentation of ETS transcription factor binding sites. Genome Res 22: 1407 – 1418.en_US
dc.identifier.citedreferenceHollenhorst PC, McIntosh LP, Graves BJ. 2011. Genomic and biochemical insights into the specificity of ETS transcription factors. Annu Rev Biochem 80: 437 – 471.en_US
dc.identifier.citedreferenceJeong H. 2010. Altered drug metabolism during pregnancy: Hormonal regulation of drug‐metabolizing enzymes. Expert Opin Drug Metab Toxicol 6: 689 – 699.en_US
dc.identifier.citedreferenceJiménez‐Díaz I, Zafra‐Gómez A, Ballesteros O, Navea N, Navalón A, Fernández MF, Olea N, Vílchez JL. 2010. Determination of Bisphenol A and its chlorinated derivatives in placental tissue samples by liquid chromatography‐tandem mass spectrometry. J Chromatogr B 878: 3363 – 3369.en_US
dc.identifier.citedreferenceKennedy M. 2008. Hormonal regulation of hepatic drug‐metabolizing enzyme activity during adolescence. Clin Pharmacol Ther 84: 662 – 673.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
em21823.pdf
Size:
315.1KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.